Trial intelligence / Profile preview

PresbiDrops (CSF-1) in Presbyopia

NCT02965664Phase 2Completed

Sponsor
Orasis Pharmaceuticals
Start
Dec 2016
Primary completion
Apr 2017
Modality
Classical Binding Small Molecules
Countries
1
01

Overview

A Phase 2 trial of pilocarpine nitrate in presbyopia, sponsored by Orasis Pharmaceuticals. Started Dec 2016; status: completed.

02

Drugs

pilocarpine nitrate
03

Conditions

presbyopia

Beyond the preview

Go deeper on NCT02965664.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02965664.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call